VTRS
Viatris Inc

3,774
Mkt Cap
$15.2B
Volume
23.2M
52W High
$16.47
52W Low
$6.85
PE Ratio
-4.46
VTRS Fundamentals
Price
$13.20
Prev Close
$13.50
Open
$13.54
50D MA
$14.22
Beta
0.79
Avg. Volume
11.92M
EPS (Annual)
-$3.00
P/B
1.03
Rev/Employee
$476,440.00
$27,822.22
Loading...
Loading...
News
all
press releases
Theravance's Q4 Earnings and Revenues Miss Estimates
TBPH's posts Q4 earnings miss despite 145% revenue surge; scraps Ampreloxetine, launches restructuring and weighs a potential sale.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Viatris Outlines Long-term Financial Targets
(RTTNews) - Viatris (VTRS) said, for combined long-term Targets through 2030, the company expects to deliver 5% to 6% total revenues CAGR, 7% to 8% adjusted EBITDA CAGR, 9% to 10% adjusted EPS CAGR...
Nasdaq News: Markets·3d ago
News Placeholder
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030 Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030 PR Newswire PITTSBURGH, March...
PR Newswire·3d ago
News Placeholder
Estradiol Hormone Patch Shortage Strains Pharmacies After Warning Lifted
Estradiol Hormone Patch Shortage Strains Pharmacies After Warning Lifted Authored by Jill McLaughlin via The Epoch Times, Some U.S. pharmacies are scrambling to fill estradiol transdermal patch...
Zero Hedge·8d ago
News Placeholder
West Pharmaceutical Services Now #396 Largest Company, Surpassing Viatris
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, West Pharmaceutical Services, Inc. (Symbol: WST) has taken over the #396 spot from Viatris Inc...
Nasdaq News: Markets·10d ago
News Placeholder
Viatris (VTRS) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·18d ago
News Placeholder
Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up
VTRS beats Q4 estimates on 5% revenue growth, boosted by strong Brands sales and Greater China gains, while returning over $1B to shareholders in 2025.
Zacks·24d ago
News Placeholder
Viatris (VTRS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Viatris (VTRS) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·24d ago
News Placeholder
Viatris (VTRS) Surpasses Q4 Earnings and Revenue Estimates
Viatris (VTRS) delivered earnings and revenue surprises of +9.62% and +5.29%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·24d ago
News Placeholder
Viatris Posts Narrower Loss In Q4; Expects Workforce Reduction Of Up To Approx. 10%
(RTTNews) - Viatris Inc. (VTRS) reported a fourth quarter net loss of $340.1 million or $0.30 per share compared to a loss of $516.5 million or $0.43 per share, prior year. The company said loss in...
Nasdaq News: Markets·24d ago
<
1
2
...
>

Latest VTRS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.